FDA / EMA Common Commentary on Submitting an initial Pediatric Study Plan (iPSP) and Pediatric Investigation Plan (PIP) for the Prevention and Treatment of COVID-19 FDA / EMA Common Commentary on Submitting an initial Pediatric Study Plan (iPSP) and Pediatric Investigation Plan (PIP) for the Prevention and Treatment of COVID-19, 02 June 2020